Figures & data
Table 1 Characteristics of patients with and without pulmonary congestion at baseline, assessed by standardized and routine procedure
Figure 1 Randomly selected chest radiographs assessed negative in the routine assessment and positive in the standardized assessment.
Abbreviations: FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; NT-proBNP, N-terminal prohormone of brain natriuretic peptide.
![Figure 1 Randomly selected chest radiographs assessed negative in the routine assessment and positive in the standardized assessment.](/cms/asset/87a41d6f-7488-4f0c-9516-58b6017f9ef6/dcop_a_52854_f0001_b.jpg)
Figure 2 ROC curves for the routine (red dashed) and standardized (blue) assessments.
Notes: Age-adjusted logrank P<0.0001 between R−/S− and R−/S+; age-adjusted P=0.049 between R+/S− and R−/S+. The results were based on the 99 index admissions.
Abbreviations: COPD, chronic obstructive pulmonary disease; R−, radiological assessment negative; R+, radiological assessment positive; S−, standardized assessment negative; S+, standardized assessment positive; ROC, receiver-operating characteristics.
![Figure 2 ROC curves for the routine (red dashed) and standardized (blue) assessments.Notes: Age-adjusted logrank P<0.0001 between R−/S− and R−/S+; age-adjusted P=0.049 between R+/S− and R−/S+. The results were based on the 99 index admissions.Abbreviations: COPD, chronic obstructive pulmonary disease; R−, radiological assessment negative; R+, radiological assessment positive; S−, standardized assessment negative; S+, standardized assessment positive; ROC, receiver-operating characteristics.](/cms/asset/3e34d56c-2a13-408b-a8b9-a97447c639d3/dcop_a_52854_f0002_c.jpg)
Figure 3 Survival after acute exacerbation of COPD, stratified by radiologic evaluation of pulmonary congestion on admission.
Abbreviations: AUC, area under the curve; ROC, receiver operating characteristics.
![Figure 3 Survival after acute exacerbation of COPD, stratified by radiologic evaluation of pulmonary congestion on admission.](/cms/asset/53388188-3920-4ce5-9fd2-c5c27965e6c3/dcop_a_52854_f0003_c.jpg)
Table 2 Number of mortalities (with mortality rates per 100 patient-years) in patients with AECOPD, by selected dichotomous covariables
Table 3 Number of mortalities (with mortality rates per 100 patient-years) in patients with AECOPD, by quartiles of selected continuous covariables
Table 4 Hazard ratios (with 95% confidence intervals) for dying during a median of 1.9 years follow up after acute exacerbation of COPD
Table 5 Geometric mean (with number of observations) of baseline NT-proBNP concentration (pg/mL), by selected dichotomous variables
Table 6 Geometric mean of baseline NT-proBNP concentrations (pg/mL), by quartiles of selected continuous variables
Table 7 Relative concentration of NT-proBNP in patients with acute exacerbation of COPD